fda indications for semaglutide Oral Wegovy approved obesity management by on December 23, 2025 Formulation: High‑dose oral (25 mg daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) High-Dose Wegovy Wins FDA Approval

Tayebi, H

Heres why some of our patients are choosing to switch to Wegovy: Proven weight loss: In clinical trials, Wegovy has helped patients lose up to 15%- 21% of their body weight, closely matching Mounjaros results

The role of the gut as a mediator is unequivocally demonstrated in models of chronic apical periodontitis (CAP), where P.g -induced CAP alters gut microbiota (increasing Lachnospiraceae , Ruminococcaceae ) and increases TMAO, thereby exacerbating aortic plaque formation

Another commenter asserted that monitoring a physiological parameter does not inherently translate to improved outcomes unless accompanied by actionable thresholds and validated interventions

Can Rybelsus cause hair loss

Diniz MO, Maini MK, Swadling L